title: Adult-to-adult living related donor renal transplantation in Yemen: the first experience.
abstract: Between May 1998 and June 2006, 31 patients (21 males and 10 females) received a renal allograft from live-related donors at the Urology and Nephrology Center in the Al-Thawra Modern General Hospital Sana'a, Republic of Yemen. The cold ischemia time ranged between 48 and 68 minutes. The immunosuppressive protocol was double therapy (steroids and mycophenolate) in the first 8 cases. The subsequent cases received triple therapy with steroids, cyclosporine and mycophenolate. Episodes of acute rejection were treated with high dose steroids while anti-thymocyte globulin (ATG) was also used in cases of vascular or steroid resistant rejection. Primary graft function was achieved in 29 recipients (93.5%). The post-transplant complications, either surgical or medical, were comparable to those reported in the literature. The kidney transplantation program started sporadically in Yemen since 1998. However, a well-established program has been running regularly since the beginning of 2005.
authors.affiliation: Urology and Nephrology Center, Al-Thawra Modern General Hospital, Sana'a, Republic of Yemen. Ibrahim_Elnono@hotmail.com
authors.forename: Ibrahiem H
authors.initials: IH
authors.lastname: El-Nono
authors.forename: Tawfiq H
authors.initials: TH
authors.lastname: Al-Ba'adani
authors.forename: Abdulilah M
authors.initials: AM
authors.lastname: Ghilan
authors.forename: Nagieb W Abu
authors.initials: NW
authors.lastname: Asba
authors.forename: Gamil M
authors.initials: GM
authors.lastname: Al-Alimy
authors.forename: Mokhtar M
authors.initials: MM
authors.lastname: Al-Massani
authors.forename: Morshed A
authors.initials: MA
authors.lastname: Noman
authors.forename: Soliman
authors.initials: S
authors.lastname: Al-Shargabe
authors.forename: Mohamed M
authors.initials: MM
authors.lastname: Al-Mansour
authors.forename: Mogahed Y
authors.initials: MY
authors.lastname: Nassar
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007674:Kidney Diseases / Q000601:surgery*; D016030:Kidney Transplantation / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D015006:Yemen / Q000453:epidemiology
chemical_list: D007166:Immunosuppressive Agents